This dedifferentiation refers to the pathological progression of PTC into ATC, during which EBV-encoded proteins such as LMP1 and EBNA2 facilitate epithelial–mesenchymal transition, anti-apoptotic signaling, and immune evasion, thereby driving tumor aggressiveness. Here, PDLIM7 is linked to neoplasm.